Skip to main content
BLUE SAIL MEDICAL CO.,LTD. logo

BLUE SAIL MEDICAL CO.,LTD. — Investor Relations & Filings

Ticker · 002382 ISIN · CNE100000MZ7 LEI · 300300X9CB08YTW0L551 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,439 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002382

About BLUE SAIL MEDICAL CO.,LTD.

https://www.bluesail.cn

Blue Sail Medical Co., Ltd. is a global provider of medical devices and protective equipment, operating primarily through health protection and cardiovascular intervention segments. The company is a major manufacturer of disposable medical gloves, including PVC and nitrile varieties, catering to healthcare and industrial sectors. Through its cardiovascular division, it develops and produces interventional cardiology products such as drug-eluting stents and balloon catheters. The company emphasizes research and development in minimally invasive surgical technologies and maintains a diverse portfolio that includes emergency care solutions and medical consumables. Its operations focus on high-quality manufacturing standards and a global distribution network to support clinical needs in various medical environments.

Recent filings

Filing Released Lang Actions
关于参与国家组织冠脉支架集中带量采购第二轮接续采购拟中选的公告
Regulatory Filings Classification · 85% confidence The document is an announcement by 蓝帆医疗 (Blue Sail Medical) regarding its subsidiary’s participation and proposed selection in a national centralized procurement program for coronary stents. It does not present financial statements, call transcripts, management or board changes, or dividend information. It is a routine regulatory announcement detailing business procurement results and risk disclosures. Therefore, it falls under the “Regulatory Filings” fallback category (RNS).
2026-05-22 Chinese
关于公司为子公司开展融资租赁业务提供担保的进展公告
Capital/Financing Update Classification · 85% confidence The document is an announcement by Blue Sail Medical Co., Ltd. regarding the progress of providing guarantees for its subsidiary’s financing lease. It details the guarantee amounts, approval history, contract terms, and financial tables. This is not a full financial report, earnings release, or management presentation, nor does it relate to share issuance, M&A, or dividends. It specifically pertains to a financing activity update (guarantee for leasing), fitting the Capital/Financing Update category.
2026-05-22 Chinese
关于实际控制人控制的主体向公司提供借款暨关联交易的进展公告
Capital/Financing Update Classification · 85% confidence The document is a formal announcement by 蓝帆医疗股份有限公司 describing a related‐party loan transaction: the company received a RMB 350 million loan from an entity controlled by its actual controller. It details the loan amount, interest rate, terms, and confirms receipt of funds. This is not a full financial report, audit, share issuance, or dividend notice, nor is it a proxy statement or delisting notice. It is an update on the company’s financing activities (capital structure). Therefore, it best fits the Capital/Financing Update category (CAP).
2026-05-22 Chinese
关于公司及子公司借款并提供担保的进展公告
Capital/Financing Update Classification · 94% confidence The document is a formal progress announcement by Blue Sail Medical Co., Ltd. (证券简称: 蓝帆医疗) concerning the status of new borrowings (RMB 6 billion) and related guarantee arrangements by the company and its subsidiaries. It provides details on loan counterparties, pledged shares, partial disbursement, and aggregate guarantee exposure. This clearly constitutes an update on company financing activities rather than an earnings report, dividend notice, or management change. Under the classification scheme, such updates fall under Capital/Financing Update (CAP).
2026-05-22 Chinese
关于蓝帆转债到期兑付暨摘牌的公告
Capital/Financing Update Classification · 85% confidence The document is a public announcement by 蓝帆医疗股份有限公司 about the maturity redemption and delisting of its convertible bonds (“蓝帆转债”), detailing key dates, redemption price, fund settlement, and listing cessation. This pertains to a corporate financing event and capital structure change (debt redemption and bond delisting), fitting the definition of a Capital/Financing Update (CAP).
2026-05-21 Chinese
上海锦天城（青岛）律师事务所关于蓝帆医疗股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 94% confidence The document is a legal opinion letter (“法律意见书”) issued by a law firm regarding the legality of the 2025 Annual General Meeting of 蓝帆医疗股份有限公司. It primarily serves as a certification/attestation on the AGM’s convening, procedures, eligibility and vote results, rather than being the AGM materials themselves or a pure voting‐results announcement. Under the Certification Rule, officer certifications or legal attestation letters should be classified as general regulatory filings. Therefore, the appropriate category is Regulatory Filings (RNS).
2026-05-20 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.